Clinical Trial Update: Capecitabine in Metastatic Breast and GI Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for capecitabine in metastatic breast and gastrointestinal cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Qamar Khan | Conditions: Breast Cancer, Gastrointestinal Cancer | Phase 2 | Status: UNKNOWN